bromocriptine has been researched along with Tremor in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (62.07) | 18.7374 |
| 1990's | 8 (27.59) | 18.2507 |
| 2000's | 2 (6.90) | 29.6817 |
| 2010's | 1 (3.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Tajali, A; Naguy, A | 1 |
| Jörg, J | 1 |
| Fincke, M; Gothóni, P; Lehtinen, M | 1 |
| Calne, DB; Newman, RP | 1 |
| Agnoli, A; Baldassarre, M; D'Urso, R; Del Roscio, S; Falaschi, P; Frajese, G; Mearelli, S; Rocco, A; Ruggieri, S | 1 |
| Bergsrud, D; Elton, RL; Racy, A; Teychenne, PF; Vern, B | 1 |
| Falk, M; Künig, G; Neubauer, M; Ransmayr, G; Wagner, M | 1 |
| Adena, MA; Broe, GA; Hely, MA; Morris, JG; O'Sullivan, DJ; Reid, WG; Williamson, PM | 1 |
| Fukuzaki, K; Kitahara, K; Kohno, Y; Koja, T | 1 |
| de Yébenes, JG; García-Ruiz, PJ; Sánchez-Pernaute, R | 1 |
| Abduljawad, KA; Bradshaw, CM; Langley, RW; Szabadi, E | 2 |
| Fukuzaki, K; Kamenosono, T; Nagata, R | 1 |
| Keens, J; Schrag, A; Warner, J | 1 |
| Battista, AF; Fuxe, K; Goldstein, M; Lew, JY; Lieberman, A; Nakamura, S | 1 |
| Hungerbühler, JP; Regli, F | 1 |
| Pöldinger, W | 1 |
| Przuntek, H | 1 |
| Baba, Y; Miyamoto, T; Ohmoto, T | 1 |
| Calne, DB; Kartzinel, R; Shoulson, I | 1 |
| Friedman, JH | 1 |
| Poddar, MK; Ray, SK | 1 |
| Garg, SK; Kulkarni, SK; Shukla, VK | 2 |
| Bratton, M; Jost, MG; Lannon, MC; Lockhart-Pretti, P; Thomas, CA | 1 |
| Agarwal, AK; Palit, G; Shanker, K; Srivastava, VK | 1 |
| Kamphuis, DJ; Lakke, JP; Staal-Schreinemachers, AL; vd Burg, W; Wesseling, H | 1 |
| Bergsrud, D; Elton, RL; Racy, A; Teychenne, PF | 1 |
| Feldman, RG; Lannon, MC | 1 |
2 review(s) available for bromocriptine and Tremor
| Article | Year |
|---|---|
[Considerations in the drug treatment of parkinsonism (author's transl)].
Topics: Amantadine; Apomorphine; Bromocriptine; Dopamine; Ergolines; Extrapyramidal Tracts; Female; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinson Disease; Phosphodiesterase Inhibitors; Piribedil; Tremor | 1978 |
[Therapy of tparkinson's disease. Clinical and pharmacological viewpoints].
Topics: Adrenergic beta-Antagonists; Amantadine; Bromocriptine; Histamine H1 Antagonists; Humans; Levodopa; Monoamine Oxidase Inhibitors; MSH Release-Inhibiting Hormone; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Posture; Psychoses, Substance-Induced; Tremor | 1979 |
9 trial(s) available for bromocriptine and Tremor
| Article | Year |
|---|---|
Bromocriptine: low-dose therapy in Parkinson disease.
Topics: Aged; Bromocriptine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Tremor | 1982 |
Effect of age and disease duration on parkinsonian motor scores under levodopa therapy.
Topics: Adult; Aged; Aging; Antiparkinson Agents; Bromocriptine; Disease Progression; Female; Gait; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Psychomotor Performance; Tremor | 1995 |
Age at onset: the major determinant of outcome in Parkinson's disease.
Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Postural Balance; Treatment Outcome; Tremor | 1995 |
Effects of bromocriptine and haloperidol on prepulse inhibition: comparison of the acoustic startle eyeblink response and the N1/P2 auditory-evoked response in man.
Topics: Acoustic Stimulation; Adolescent; Adult; Blinking; Bromocriptine; Dopamine Antagonists; Electromyography; Evoked Potentials, Auditory; Haloperidol; Hemodynamics; Humans; Male; Prolactin; Reflex, Startle; Salivation; Tremor | 1999 |
Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man.
Topics: Acoustic Stimulation; Adolescent; Adult; Affect; Attention; Bromocriptine; Dopamine Agonists; Dopamine Antagonists; Double-Blind Method; Haloperidol; Hemodynamics; Humans; Male; Prolactin; Reflex, Startle; Salivation; Tremor | 1998 |
Ropinirole for the treatment of tremor in early Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Double-Blind Method; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome; Tremor | 2002 |
Therapy of extrapyramidal side effects, with particular reference to persistent dyskinesia and lithium tremor.
Topics: Adolescent; Adult; Amantadine; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Female; Humans; Lithium; Male; Middle Aged; Oxprenolol; Tremor | 1978 |
Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Tremor | 1976 |
Low-dose bromocriptine therapy in Parkinson's disease: double-blind, placebo-controlled study.
Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Random Allocation; Tremor | 1986 |
18 other study(ies) available for bromocriptine and Tremor
| Article | Year |
|---|---|
Bromocriptine mitigated paliperidone metabolic and neuro-hormonal side effects and improved negative domain in a case of early onset schizophrenia.
Topics: Adolescent; Antipsychotic Agents; Bromocriptine; Humans; Hyperprolactinemia; Male; Paliperidone Palmitate; Schizophrenia; Treatment Outcome; Tremor; Weight Gain | 2016 |
[Therapeutic concept in Parkinson disease].
Topics: Adrenergic beta-Antagonists; Amantadine; Antidepressive Agents, Tricyclic; Benzodiazepines; Bromocriptine; Depression; Fludrocortisone; Humans; Hypotension, Orthostatic; Levodopa; Midodrine; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Thalamus; Tremor | 1983 |
Drugs for Parkinson's disease reduce tremor induced by physostigmine.
Topics: Amantadine; Animals; Antiparkinson Agents; Atropine; Biperiden; Bromocriptine; Male; Physostigmine; Pimozide; Rats; Rats, Inbred Strains; Tremor | 1983 |
Diagnosis and management of Parkinson's disease.
Topics: Bromocriptine; Diagnosis, Differential; Humans; Levodopa; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Tremor | 1984 |
Presynaptic neuron and postsynaptic dopamine receptor function in long term treatment of Parkinson's disease: a neuroendocrine study.
Topics: Aged; Apomorphine; Benserazide; Bromocriptine; Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Nomifensine; Parkinson Disease; Prolactin; Receptors, Dopamine; Selegiline; Tremor | 1980 |
Anti-tremor activity of talipexole produced by selective dopamine D2 receptor stimulation in cynomolgus monkeys with unilateral lesions in the ventromedial tegmentum.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Animals; Azepines; Behavior, Animal; Bromocriptine; Dopamine Agents; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Hypnotics and Sedatives; Injections, Subcutaneous; Levodopa; Macaca fascicularis; Male; Receptors, Dopamine D2; Tegmentum Mesencephali; Tremor | 1997 |
[A comparative study of the effect of bromocriptine and pergolide on Parkinson disease].
Topics: Aged; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Pergolide; Retrospective Studies; Tremor | 1997 |
Effects of ropinirole on various parkinsonian models in mice, rats, and cynomolgus monkeys.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Catalepsy; Dopamine Agonists; Indoles; Macaca fascicularis; Male; Mice; Oxidopamine; Parkinsonian Disorders; Rats; Reserpine; Tremor | 2000 |
Dopaminephilic properties of ergot alkaloids.
Topics: Acetonitriles; Animals; Bromocriptine; Corpus Striatum; Ergolines; Ergot Alkaloids; Haplorhini; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine; Spiperone; Substantia Nigra; Synaptosomes; Tremor; Tyrosine 3-Monooxygenase | 1978 |
[Experimental and clinical study on the dopaminergic receptor stimulating agents (author's transl)].
Topics: Adult; Aged; Animals; Bromocriptine; Dopamine; Female; Haplorhini; Humans; Male; Middle Aged; Parkinson Disease; Piperazines; Piribedil; Receptors, Dopamine; Tremor | 1977 |
"Rubral" tremor induced by a neuroleptic drug.
Topics: Adult; Benztropine; Bromocriptine; Corpus Striatum; Fluphenazine; Humans; Male; Neural Pathways; Red Nucleus; Substantia Nigra; Tremor | 1992 |
Interaction of central serotonin and dopamine in the regulation of carbaryl-induced tremor.
Topics: 5-Hydroxytryptophan; Acetylcholinesterase; Animals; Atropine; Behavior, Animal; Brain Chemistry; Bromocriptine; Carbaryl; Corpus Striatum; Dopamine; Haloperidol; Hydroxyindoleacetic Acid; Male; Methysergide; Physostigmine; Rats; Serotonin; Tremor | 1990 |
GABAergic, dopaminergic and cholinergic interaction in tremorine-induced tremors in mice.
Topics: Animals; Bicuculline; Bromocriptine; Dopamine; GABA Antagonists; gamma-Aminobutyric Acid; In Vitro Techniques; Male; Mice; Neurotransmitter Agents; Parasympathetic Nervous System; Picrotoxin; Scopolamine; Tremor; Tremorine | 1988 |
Comprehensive care of the patient with Parkinson's disease.
Topics: Aged; Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Patient Care Planning; Patient Care Team; Tremor | 1986 |
Antiparkinsonian activity and behavioural effects of newer quinazolinones.
Topics: Animals; Antiparkinson Agents; Behavior, Animal; Bromocriptine; Catatonia; Chemical Phenomena; Chemistry; Female; Male; Mice; Motor Activity; Quinazolines; Rats; Receptors, Dopamine; Tremor | 1987 |
Antagonism by naloxone of anti-tremorine effect of bromocriptine in mice.
Topics: Animals; Bromocriptine; Male; Mice; Naloxone; Scopolamine; Tremor; Tremorine | 1987 |
Bromocriptine: long-term low-dose therapy in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Movement; Muscle Rigidity; Parkinson Disease; Tremor | 1986 |
Parkinson disease. Individualizing therapy.
Topics: Aged; Bromocriptine; Carbidopa; Central Nervous System Diseases; Diagnosis, Differential; Gait; Humans; Levodopa; Male; Motor Activity; Parkinson Disease; Psychoses, Substance-Induced; Tremor | 1985 |